Preclinical investigation on TNBC xenograft mice has demonstrated a satisfactory response (treatment) to Iodine-124 (124I)-tagged B-B4 antibody (targeting syndecan-1; CD138 antigen) and a good visualisation of the TNBC tumour (134–155). The gene discussed is SDC1; the disease is neoplasm.